Masaaki Ogai
Hamamatsu, 4308558, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial.
Journal: Dermatology and therapy
Published: March 30, 2020
Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex.
Journal: Frontiers in medicine
Published: August 09, 2019
Erythema multiforme like reaction to santos rosewood (Machaerium scleroxylon) and Torreya nucifera.
Journal: BMJ case reports
Published: May 17, 2019
Clinical course of the first Japanese family with Marie Unna hereditary hypotrichosis: a follow-up report.
Journal: European journal of dermatology : EJD
Published: June 29, 2018
Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.
Journal: JAMA dermatology
Published: May 26, 2018
Identification of a novel heterozygous mutation in the first Japanese case of Marie Unna hereditary hypotrichosis.
Journal: The Journal of dermatology
Published: January 09, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026